CPTCF (Cytophage Technologies) Total Assets: $2.42 Mil (As of Dec. 2025)


CPTCF Cytophage Technologies Ltd CPTCF
18 GF Score
Price $0.21
! 1 Warning Sign
View Full Analysis

What is Cytophage Technologies Total Assets?

Cytophage Technologies CPTCF 18 Total Assets is $2.42 Mil as of Dec. 2025. GuruFocus rates CPTCF with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Cytophage Technologies's Total Assets for the quarter that ended in Dec. 2025 was $2.42 Mil.

During the past 12 months, Cytophage Technologies's average Total Assets Growth Rate was -17.10% per year. During the past 3 years, the average Total Assets Growth Rate was 25.20% per year.

During the past 5 years, Cytophage Technologies's highest 3-Year average Total Assets Growth Rate was 51.10%. The lowest was 25.20%. And the median was 38.15%.

Total Assets is connected with ROA %. Cytophage Technologies's annualized ROA % for the quarter that ended in Dec. 2025 was -99.07%. Total Assets is also linked to Revenue through Asset Turnover. Cytophage Technologies's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Cytophage Technologies  (OTCPK:CPTCF) Total Assets Explanation

Total Assets is connected with ROA %.

Cytophage Technologies's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-2.336/( (2.299+2.417)/ 2 )
=-2.336/2.358
=-99.07 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cytophage Technologies's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (2.299+2.417)/ 2 )
=0/2.358
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cytophage Technologies Total Assets Related Terms

Cytophage Technologies Total Assets Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Total Assets Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
4.56 2.72 4.06 3.47 2.42

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.47 2.63 3.00 2.30 2.42
CPTCF
18GF Score
Cytophage Technologies Ltd CPTCF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytophage Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cytophage Technologies's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=1.151+1.266
=2.42

Cytophage Technologies's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=1.151+1.266
=2.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $2.42 Mil mean?
Cytophage Technologies (CPTCF) has a Total Assets of $2.42 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Cytophage Technologies and its competitors.
Is Cytophage Technologies' Total Assets too high?
Cytophage Technologies' current Total Assets is $2.42 Mil. Overall, Cytophage Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cytophage Technologies' Total Assets compare to VRTX and REGN?
Cytophage Technologies' Total Assets of $2.42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Total Assets is $2.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (CPTCF) has a current Total Assets of $2.42 Mil. The current Total Assets is $2.42 Mil. Cytophage Technologies' overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Cytophage Technologies (CPTCF), the current Total Assets is $2.42 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Other Exchanges CYTO.H:Canada
Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.
18GF Score

Get the complete analysis for CPTCF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price